Menu
Annual · values202620252024202320222021202020192018201720162015
Operating Cash Flow1.42 B USD1.09 B USD911.34 M USD780.47 M USD764.46 M USD551.25 M USD437.38 M USD310.83 M USD233.44 M USD144.01 M USD80.15 M USD67.57 M USD
Depreciation & Amortization6.00 M USD6.00 M USD7.00 M USD9.00 M USD19.86 M USD14.07 M USD14.28 M USD13.82 M USD8.46 M USD3.93 M USD
Stock-Based Compensation472.70 M USD437.35 M USD393.73 M USD351.91 M USD234.64 M USD185.00 M USD115.91 M USD76.42 M USD
Capital Expenditures3.11 M USD8.44 M USD9.63 M USD6.92 M USD21.15 M USD26.53 M USD
Cash Flow from Investing-1.10 B USD-700.14 M USD-1.08 B USD-1.01 B USD-346.15 M USD-333.63 M USD-516.91 M USD-103.87 M USD-154.52 M USD-96.75 M USD-96.68 M USD-272.02 M USD
Cash Flow from Financing-9.33 M USD26.11 M USD-16.19 M USD-19.38 M USD-4.14 M USD33.82 M USD10.01 M USD25.91 M USD20.77 M USD37.98 M USD19.41 M USD71.26 M USD
Dividends Paid
Stock Buybacks169.95 M USD0 USD0 USD
Free Cash Flow434.26 M USD302.39 M USD223.81 M USD137.09 M USD59.00 M USD41.04 M USD

Veeva Systems Inc. is a cloud software company focused on the life sciences industry. It provides industry-specific applications that help pharmaceutical, biotechnology, and other healthcare organizations manage customer relationships, clinical operations, quality processes, regulatory content, and commercial activities within a compliant digital environment. The company’s platform is designed to support critical workflows across development, manufacturing, and go-to-market functions, with products that emphasize data integrity, collaboration, and regulatory alignment. Veeva Systems serves a broad range of life sciences customers, from emerging biotech firms to global pharmaceutical companies, and plays a significant role in the modernization of software systems used across healthcare and regulated industries.